tiprankstipranks
Cabaletta Bio (CABA)
NASDAQ:CABA
US Market

Cabaletta Bio (CABA) Financial Statements

399 Followers

Cabaletta Bio Financial Overview

Cabaletta Bio's market cap is currently ―. The company's EPS TTM is $-1.661; its P/E ratio is -10.21; Cabaletta Bio is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -20.89M$ -16.45M$ -14.49M$ -15.85M$ -16.30M
EBITDA$ -20.93M$ -16.75M$ -14.29M$ -15.50M$ -15.99M
Net Income Common Stockholders$ -20.89M$ -16.45M$ -14.49M$ -15.85M$ -15.69M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 241.25M$ 164.39M$ 176.33M$ 93.84M$ 106.55M
Total Assets$ 253.65M$ 173.29M$ 184.64M$ 103.45M$ 116.97M
Total Debt$ 5.02M$ 4.27M$ 4.20M$ 4.67M$ 5.14M
Net Debt$ -236.23M$ -160.12M$ -172.13M$ -89.17M$ -101.41M
Total Liabilities$ 17.45M$ 12.36M$ 10.50M$ 11.80M$ 12.45M
Stockholders Equity$ 236.20M$ 160.92M$ 174.14M$ 91.65M$ 104.52M
Cash Flow-
Free Cash Flow$ -16.63M$ -12.67M$ -11.95M$ -12.99M$ -12.45M
Operating Cash Flow$ -16.45M$ -12.60M$ -11.89M$ -12.61M$ -12.13M
Investing Cash Flow$ 1.14M$ -65.00K$ -48.14M$ 24.62M$ -316.00K
Financing Cash Flow$ 93.05M$ 98.00K$ 94.26M$ 226.00K$ 32.89M
Currency in USD

Cabaletta Bio Earnings and Revenue History

Cabaletta Bio Debt to Assets

Cabaletta Bio Cash Flow

Cabaletta Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis